China National Medicines Corporation Ltd.

SSE:600511.SS

31.11 (CNY) • At close June 10, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 50,597.4549,696.04645,498.58446,468.60340,378.60844,644.47638,739.82736,284.74613,386.41712,078.19411,538.34310,081.4748,591.6327,042.2465,918.0385,194.64,385.4723,573.7882,807.042,333.8821,801.0121,472.0371,223.8211,220.8951,098.715794.415
Cost of Revenue 47,002.22645,704.38741,676.31842,837.537,235.80140,736.87235,320.73133,450.72512,392.5511,117.88510,625.8839,334.6558,023.6546,592.725,394.9814,730.3693,978.8483,207.2292,550.7732,128.771,619.8691,312.0211,091.0541,105.255986.227700.446
Gross Profit 3,595.2243,991.6583,822.2663,631.1023,142.8073,907.6053,419.0962,834.022993.867960.309912.46746.819567.978449.526523.057464.231406.625366.559256.267205.112181.143160.016132.767115.64112.48893.969
Gross Profit Ratio 0.0710.080.0840.0780.0780.0880.0880.0780.0740.080.0790.0740.0660.0640.0880.0890.0930.1030.0910.0880.1010.1090.1080.0950.1020.118
Reseach & Development Expenses 73.70871.19766.99655.75251.87144.92830.44321.88413.12913.4669.878.8847.3934.1291.9900000000000
General & Administrative Expenses 70.13970.38753.60656.58442.82657.7663.87961.4526.00536.58440.6338.65441.50932.53532.595108.466105.697109.24199.42790.67173.18759.54354.67644.80740.12434.021
Selling & Marketing Expenses 378.075523.599956.496940.4791,034.9531,048.4121,043.659694.011215.466228.846221.316201.043166.463124.719105.6579.80770.57956.02947.41345.1348.04547.32935.66735.32441.03236.421
SG&A 448.214593.9861,010.103997.0631,077.7791,106.1711,107.538755.461241.472265.43261.946239.697207.972157.254138.245188.273176.276165.269146.84135.801121.232106.87290.34380.13181.15570.442
Other Expenses 395.88382.117343.45382.032309.783404.625-15.25-29.09816.30234.612118.05291.151131.072101.62930.75923.34630.1520.1422.3161.8420.1273.8273.0732.8546.4810.78
Operating Expenses 917.8021,047.3011,420.5481,434.8471,439.4331,555.7251,507.6581,107.166430.604414.902398.486354.024318.015242.259214.199201.447183.62171.081152.465138.489123.51108.16591.76881.83782.64571.253
Operating Income 2,677.4222,944.3582,694.9232,447.2741,913.2182,436.0812,038.4641,769.793694.916633.263583.405436.714292.954240.007368.186272.688220.963194.431116.07672.38759.75155.15246.22634.98125.93517.739
Operating Income Ratio 0.0530.0590.0590.0530.0470.0550.0530.0490.0520.0520.0510.0430.0340.0340.0620.0520.050.0540.0410.0310.0330.0370.0380.0290.0240.022
Total Other Income Expenses Net -23.81-13.468-7.038-2.4684.128-9.524-15.25-29.098-104.39134.46441.5491.10547.907101.40230.63622.55229.775-0.533-0.841-0.173-3.124-1.046-1.86-0.081-0.0990.122
Income Before Tax 2,653.6122,930.892,687.8862,444.8061,917.3462,426.5572,023.2141,740.695711.085667.727624.945527.818423.915341.409398.822295.239250.738193.898115.2872.21456.62754.10644.36634.925.83617.861
Income Before Tax Ratio 0.0520.0590.0590.0530.0470.0540.0520.0480.0530.0550.0540.0520.0490.0480.0670.0570.0570.0540.0410.0310.0310.0370.0360.0290.0240.022
Income Tax Expense 523.832596.42559.181516.303408.095546.08430.557401.496147.142135.418126.894103.70779.96165.54485.5665.81854.36163.73634.66328.74226.49921.44219.06815.40612.0947.702
Net Income 2,000.1272,145.9991,964.0581,754.0841,382.6881,603.8991,404.0951,141.485547.607512.845482.654411.51335.816271.261310.019226.599193.826131.10284.61150.3735.03232.73926.18319.85613.98910.159
Net Income Ratio 0.040.0430.0430.0380.0340.0360.0360.0310.0410.0420.0420.0410.0390.0390.0520.0440.0440.0370.030.0220.0190.0220.0210.0160.0130.013
EPS 2.652.842.62.321.832.111.831.551.431.071.010.860.70.570.650.470.40.270.170.0810.0560.0530.0420.0420.0290.021
EPS Diluted 2.652.842.62.321.832.111.831.551.431.071.010.860.70.570.650.470.40.270.170.0810.0560.0530.0420.0420.0290.021
EBITDA 2,927.8062,825.8962,904.3752,667.3432,146.7542,605.2882,037.5271,872.9261,659.174706.868794.725499.889408.428400.568447.478280.754294.992226.176142.26799.88771.967.29553.26842.94331.87122.715
EBITDA Ratio 0.0580.0570.0640.0570.0530.0580.0530.0520.1240.0590.0690.050.0480.0570.0760.0540.0670.0630.0510.0430.040.0460.0440.0350.0290.029